Oscar Health Stock Financial Analysis and Performance Review

Oscar Health Stock has seen significant growth since its IPO in 2019. The company's revenue more than doubled in 2020, reaching $3.2 billion.

This rapid expansion is largely attributed to the growing demand for health insurance and Oscar's innovative approach to the industry. Oscar's unique model allows for more personalized and tech-driven healthcare experiences.

As a result, Oscar's stock price has also seen significant gains, with a 50% increase in 2020 alone. This growth has made Oscar Health Stock a notable player in the healthcare sector.

Investors are taking notice of Oscar's momentum and potential for continued growth.

Intriguing read: Oscar Health Insurance Pros and Cons

Oscar Health's revenue reached $5.86 billion in 2023, a 46.95% increase from the previous year's $3.99 billion. This significant growth is a testament to the company's expanding presence in the market.

Losses narrowed to -$270.73 million in 2023, a 55.35% decrease from the previous year. This improvement in financial performance is a positive sign for the company's future prospects.

Oscar Health's medical loss ratio (MLR) has been steadily decreasing, reaching 86.4% in the fourth quarter of last year, down from 91.6% in the same period the previous year. This trend is expected to continue, with analysts predicting the MLR to drop to 75.7% in the first quarter, the lowest in 12 quarters.

The company is also seeing growth in membership through the Affordable Care Act (ACA), with its 11th year as a prominent player in the ACA marketplace contributing to its success. This, combined with the implementation of artificial intelligence to answer simple questions, is helping to drive Oscar Health's growth and reduce expenses.

Suggestion: Oscar Health Insurance Ratings

Oscar Health's revenue in 2023 was a whopping $5.86 billion, a 46.95% increase from the previous year.

This significant growth is a testament to the company's expanding presence in the health insurance market. Oscar Health's losses, however, were still substantial at -$270.73 million.

Despite the losses, Oscar Health's financial performance is showing signs of improvement, with a decrease of 55.35% in losses compared to the previous year.

For another approach, see: Oscar Wassermann

The company's revenue growth is likely due to its continued expansion into the ACA marketplace, where membership is growing rapidly.

Oscar Health's medical loss ratio, or MLR, is also steadily decreasing, from 91.6% in the previous year to 86.4% in the fourth quarter.

Here's a summary of Oscar Health's financial performance over the past few years:

The company's MLR is expected to continue decreasing, with analysts predicting a drop to 75.7% in the first quarter, the lowest it's been in 12 quarters.

Oscar Health's Chief Financial Officer, Richard Blackley, is optimistic about the company's future, stating that there is room to run in terms of driving MLR performance through disciplined pricing.

Shareholder Returns are a crucial aspect of any company's financial analysis. OSCR's 1-year return of 23.8% far exceeded the US Insurance industry's return of 18.3%.

The table below breaks down OSCR's returns over different time periods compared to the US Insurance industry and the US Market.

OSCR's 1-year return was also higher than the US Market's return of 21.3%.

According to 8 analysts, the average rating for OSCR stock is "Hold". This suggests a neutral market sentiment towards the company.

The 12-month stock price forecast is $21.56, which is a significant increase of 52.05% from the latest price. This kind of growth potential can be a major draw for investors.

Oscar Health has recently shown improved relative price performance, a significant development for investors.

This improvement is reflected in the company's Relative Strength Rating, which has been upgraded to show improving technical performance.

According to the latest data, Oscar Health has hit an 80-Plus Relative Strength Rating benchmark, a notable achievement.

Here's a brief overview of Oscar Health's performance:

These numbers demonstrate Oscar Health's impressive growth over the past few years, with a significant increase in value despite a decline since its IPO.

The company's stock has also seen a 3.81% increase in the past month, indicating a positive trend.

Oscar Health's Relative Strength Rating upgrade is a promising sign for investors, suggesting that the company's stock may continue to perform well in the future.

Oscar Health's financial performance has been impressive, with revenue increasing by 46.95% in 2023 to $5.86 billion, a significant jump from the previous year's $3.99 billion.

Despite this growth, the company still reported a loss of -$270.73 million in 2023, a decrease of -55.35% compared to the previous year's loss.

Oscar Health's share price has also seen significant growth, with a year-to-date surge of almost 98% as of May 2, 2023.

Here are some key financial metrics from the company's recent earnings calls:

The company has exceeded its goals set in 2021, including achieving 1 million members, $5.7 billion in direct and assumed policy premiums, an 83% Medical Loss Ratio (MLR), and a total company adjusted EBITDA loss of $222 million.

Oscar Health's performance is impressive, especially when compared to the S&P. The company's stock has seen a +27.06% return over the past year, outpacing the S&P's +21.90% return.

Looking at the 5-year performance, the S&P has seen a significant +78.45% return, while Oscar Health's return is not specified. However, the company's stock has still managed to deliver a strong performance.

Here's a comparison of Oscar Health's return to the S&P's return over various time periods:

Oscar Health's return has been volatile, with a -59% return since its IPO, while the S&P has seen a +53% return over the same period.

During Q2 2022, Oscar Health, Inc. held an earnings call for the period ending June 30, 2022.

The earnings call was for Oscar Health, Inc.'s Q2 2022 performance.

This period marked the end of the second quarter for the company.

The specific date of the earnings call was not mentioned in the transcript.

Oscar Health, Inc. reported its Q2 2022 performance during the call.

The transcript of the call provides a detailed account of the company's financials and operations during that period.

However, the exact details of the company's performance during Q2 2022 are not explicitly stated in the provided information.

During the Q3 2021 earnings call, Oscar Health, Inc. reported its financial results for the period ending September 30, 2021.

The company's earnings call was for the period ending September 30, 2021.

Oscar Health stock took a significant hit on Tuesday, plummeting by 22%.

A prominent investment bank wasn't optimistic about the company's prospects, which likely contributed to the stock's decline.

This news may have caught investors off guard, especially those who had been following Oscar Health's previous earnings calls. In its Q2 2022 earnings call, the company reported on its performance for the period ending June 30, 2022.

In contrast, Oscar Health's Q3 2021 earnings call was for the period ending September 30, 2021, and likely showed different financial results.

The company's stock price drop may have been a surprise to some, but it's essential for investors to stay informed about market trends and company performance.

For another approach, see: How Are Stock Speculators Different from Stock Investors

Oscar Health's stock price has been quite volatile, dipping 5.04% at one point.

The current stock price is $19.23 per share, a significant drop from its previous value.

Investors seem to have responded positively to Oscar Health's latest quarterly update, causing the stock to skyrocket.

A trading volume of 1.242 million shares indicates a high level of interest in the stock.

Oscar Health's stock price has been known to fluctuate significantly, with a 5.04% drop in a single trading session. This volatility is not uncommon for the company, which has experienced a 12% average weekly movement over the past year.

The insurance industry as a whole has seen an average movement of 4.1%, while the market average is 6.4%. This puts Oscar Health's volatility at a higher level than both its peers and the overall market.

Here's a comparison of Oscar Health's volatility to that of the market and industry:

The company's stock price has been stable over the past year, but still higher than 75% of US stocks. This makes it essential for investors to keep a close eye on Oscar Health's performance and make informed decisions accordingly.

The US healthcare industry is indeed broken, according to Mark Bertolini, Oscar Health CEO. He made this statement on "Squawk Box" while discussing the new administration's impact on the healthcare sector.

The industry's brokenness is a concern that many have been voicing, and it's not just about opinions. The fact that Oscar Health's CEO feels this way suggests a deeper issue.

Mark Bertolini joined "Squawk Box" to share his insights on the matter, highlighting the need for change in the healthcare sector.

A different take: Change Healthcare Stock Symbol

The competition in the market is fierce, with several players vying for dominance.

One of the key competitors is Company A, which has been making waves with its innovative approach to product development. They've managed to reduce production costs by 30% through the use of advanced technology.

Another major player is Company B, which has been expanding its market share through strategic partnerships. They've formed alliances with several key suppliers to secure a steady supply of raw materials.

Company C is also a notable competitor, with a strong focus on customer service. They've implemented a comprehensive customer support system, resulting in a 25% increase in customer satisfaction.

The market is also seeing the rise of new entrants, such as Startup X, which is disrupting the industry with its agile business model. They've been able to quickly adapt to changing market conditions and capitalize on emerging trends.

These competitors are forcing established players to innovate and improve their offerings to stay ahead of the curve.

Oscar Health stock has already doubled this year, making it an attractive investment opportunity.

Shares of the tech-enabled health insurance company have been on a roll, with analyst price target lifts contributing to the surge.

Encouraging 2023 guidance has also pushed the shares higher, indicating a strong outlook for the company.

Oscar Health's little-known subsidiary has the potential to transform American healthcare, which could multiply your investment.

According to the OSCR earnings call for the period ending March 31, 2022, the company has shown significant growth and promise.

Consider reading: What Are Stocks and Shares

Oscar Health stock has seen significant fluctuations in its price over the past year, with a 3.81% increase in the last month and a 23.84% rise in the last year.

The stock's current price is US$14.18, which is a far cry from its 52-week high of US$23.79. In fact, it's down 59.25% from its IPO price.

Here are some key statistics about Oscar Health's stock:

The stock's volatility has been quite high, with a 68.53% volatility percentage. However, its 14-Day RSI of 46.89 indicates that it may be due for a bounce.

The current share price of Oscar Health is $14.18. This is a significant drop from its 52-week high of $23.79.

Over the past year, Oscar Health has seen a 23.84% increase in its share price. However, in the past three months, the stock has dropped by 19.34%.

Here's a brief summary of Oscar Health's price history:

Oscar Health's share price has been volatile, with a 3.1% drop on October 2. Despite this, the stock has shown some resilience, recovering slightly from its intraday low of $19.22.

Oscar Health is forming a cup base, which is a bullish technical pattern that can signal a potential breakout.

A buy point of 18.55 has been identified for Oscar Health stock, according to MarketSurge.

The cup base is a sign of a strong foundation for the stock, indicating that it's ready to make a move upwards.

Oscar Health shares are well above their key moving averages, which is a bullish sign that suggests the stock is in a strong uptrend.